We understand the importance of affordable healthcare and have tried our best to keep our prices low. Rising provider costs, inflation, and the complexities of providing adequate support have made a price increase necessary. We announced this increase in January and for our valued earlier patients like you, we have kept the price unchanged until August 1, 2023. We want you to know that our team at ADHD Online genuinely cares about your healthcare journey.
We are proud to offer our ADHD Online treatment path as an affordable and comprehensive option that is comparable to the costs of in-person office visits. We have carefully analyzed the overall yearly cost of treatment for traditional in-person visits and compared it to the costs of our online services. Our analysis consistently shows that our prices align with the costs of receiving care in-person, taking into account all the necessary expenses.
We are continuously improving our service and value the opportunity to be your trusted partner in this ongoing journey. We encourage you to explore our award-winning podcast, Refocused with Lindsay Guentzel and articles that provide valuable insights and guidance to help you live your best life with ADHD. These resources are designed to support and empower you along the way.
If you have any questions or feedback regarding this issue, please click here to reach out to us.
Mentavi Health is conducting ADHD research and is accepting a limited number of participants. Participants in our clinical study will get an ADHD Assessment at no cost.
ADHD Online will be closed on Monday, January 19, in observance of Martin Luther King Jr. Day.
Live support will be unavailable, but you may still submit a request or leave a message. We’ll respond when we return.
Our Diagnostic Evaluation is always available—on your schedule.
Our website remains open 24/7 for scheduling appointments, accessing ADHD resources, and viewing recorded webinars.
In this form, your practitioner will request that ADHD Online continue to provide uninterrupted care